ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2018

Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders.

E Domi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.